Cardiovascular Drugs Practice Questions

Q: Niacin therapy is contraindicated in diabetes because it

Increases the blood sugar levels. ***Increases the blood sugar levels*** - **Niacin** can cause an increase in **insulin resistance** and glucose production, leading to elevated **blood sugar levels**. - This effect makes it contraindicated or used with extreme caution in patients with **diabetes mellitus**, as it can exacerbate **hyperglycemia**. *Causes scleroderma* - **Scleroderma** is a **chronic autoimmune** disorder characterized by widespread **fibrosis** and vascular dysfunction; it is not typically caused by niacin. - While niacin can have various side effects, **scleroderma** is not a known adverse reaction of this medication. *Difficult to give injection* - **Niacin** is available in various formulations, including **oral tablets** and **extended-release preparations**, which are easy to administer. - The mode of administration (injectable difficulty) is not a primary reason for its **contraindication in diabetes**. *Increases the metabolism of oral hypoglycemic drugs* - **Niacin** does not typically increase the **metabolism of oral hypoglycemic drugs**; rather, its primary concern in diabetes is its direct impact on **glucose metabolism**. - The interaction of niacin with **antidiabetic medications** is mainly related to its effect on **blood glucose levels**, requiring dose adjustments.

Q: Which drug is most classically associated with QT interval prolongation?

Quinidine. ***Quinidine*** - **Quinidine** is a Class IA antiarrhythmic drug that is the **classic textbook example** of drug-induced QT interval prolongation. - It blocks **sodium channels** and **potassium channels**, specifically delayed rectifier potassium channels (IKr). - This blockade of potassium channels **slows repolarization** of the cardiac myocyte, thereby prolonging the **QT interval** and increasing the risk of **Torsades de Pointes**. - Historically, quinidine has been the **prototype drug** used to teach this adverse effect in medical education. *Magnesium Sulfate* - **Magnesium sulfate** is used to **treat Torsades de Pointes**, a polymorphic ventricular tachycardia often associated with **QT prolongation**, but it does not primarily cause QT prolongation itself. - Its mechanism involves stabilizing the cardiac membrane and reducing abnormal electrical activity, rather than lengthening the **QT interval**. *Lignocaine* - **Lignocaine** (Lidocaine) is a Class IB antiarrhythmic drug that primarily blocks **sodium channels**, shortening the action potential duration in some cardiac tissues. - It does **not** significantly prolong the **QT interval**; in some cases, it can even shorten it, making it safer in patients with pre-existing QT prolongation. *Amiodarone* - **Amiodarone** is a Class III antiarrhythmic drug that blocks multiple channels, including **potassium channels**, leading to significant **QT interval prolongation**. - While amiodarone does prolong the QT interval considerably, the question asks for the **"most classically associated"** drug, which is quinidine—the historical prototype for this adverse effect. - The associated risk of **Torsades de Pointes** with amiodarone is lower than with Class IA agents like quinidine due to its **less proarrhythmic** profile, making quinidine the more classic teaching example.

Q: Drugs acting on K+ channels include which of the following?

Nicorandil. ***Nicorandil*** - **Nicorandil** is a **potassium channel activator** that causes vasodilation by opening ATP-sensitive potassium channels in vascular smooth muscle cells. - This action leads to hyperpolarization of the cell membrane, making it more difficult for calcium influx and thus promoting relaxation and **vasodilation**. *Spironolactone* - **Spironolactone** is an **aldosterone antagonist** that works by blocking aldosterone receptors in the renal collecting tubules. - Its main effect is to increase sodium and water excretion while **conserving potassium**, making it a potassium-sparing diuretic, but it does not directly act on potassium channels for its primary mechanism. *Amiloride* - **Amiloride** is a **potassium-sparing diuretic** that directly inhibits **epithelial sodium channels (ENaC)** in the collecting duct. - By blocking sodium reabsorption, it indirectly reduces potassium secretion, thus conserving potassium, but it does not directly affect potassium channels. *Methyldopa* - **Methyldopa** is a **centrally acting alpha-2 adrenergic agonist** that reduces sympathetic outflow from the central nervous system. - It decreases peripheral vascular resistance and heart rate, leading to a reduction in blood pressure, and does not directly interact with potassium channels.

Q: Which of the following methods can reduce flushing caused by niacin?

All of the options. ***All of the options*** - **All three methods** (tachyphylaxis, laropiprant, and premedication with aspirin) are effective strategies for reducing niacin-induced flushing. - This demonstrates that multiple pharmacological and physiological approaches can mitigate this common side effect of niacin therapy. **Why each method works:** **Tachyphylaxis:** - Refers to the rapid decrease in response to a drug after repeated administration - With continued niacin use, tolerance develops and flushing intensity decreases over time - This is a natural adaptive response, though not an immediate solution for initial flushing episodes **Laropiprant:** - A selective antagonist of the **prostaglandin D2 receptor 1 (DP1)** - Specifically developed to reduce niacin-induced flushing by blocking prostaglandin D2-mediated vasodilation - Was marketed in combination with niacin (though later withdrawn due to other safety concerns) **Premedication with aspirin:** - **Aspirin** or other NSAIDs taken approximately 30 minutes before niacin administration - Reduces flushing by inhibiting **prostaglandin synthesis**, particularly prostaglandin D2 - Prostaglandins are key mediators of the cutaneous vasodilation that causes flushing

Q: Which of the following medications is primarily used to decrease serum triglycerides?

Fibrates. ***Fibrates*** - Fibrates, such as **gemfibrozil** and **fenofibrate**, are primarily used to activate **PPAR-alpha**, leading to increased lipoprotein lipase activity and reduced hepatic triglyceride synthesis. - This effectively lowers **serum triglyceride levels** by 20-50% and can also increase HDL cholesterol. *Statin* - Statins primarily inhibit **HMG-CoA reductase**, the rate-limiting enzyme in cholesterol synthesis, which makes them highly effective at lowering **LDL cholesterol**. - While they can cause a modest reduction in triglycerides (10-30%), this is not their primary mechanism or indication. *Ezetimibe* - Ezetimibe works by inhibiting the absorption of **cholesterol** at the brush border of the small intestine, thereby lowering **LDL cholesterol**. - It has minimal effect on **triglyceride levels** and is not indicated for primary triglyceride reduction. *Niacin* - Niacin, or **nicotinic acid**, reduces the liver's production of VLDL (which contains triglycerides) and LDL, and also increases HDL cholesterol. - While it can significantly lower triglycerides, its use is often limited by bothersome side effects such as **flushing** and itchiness, making fibrates generally preferred for primary triglyceride lowering due to better tolerability.

Q: Fenoldopam is used in the management of?

Hypertensive emergencies. ***Hypertensive emergencies*** - **Fenoldopam** is a **dopamine D1 receptor agonist** that causes rapid, dose-dependent peripheral vasodilation and increased renal blood flow, making it suitable for acute blood pressure reduction during hypertensive emergencies. - Its **rapid onset** and short half-life allow for precise control of blood pressure, and its **benefit** in preserving or improving renal function is particularly beneficial in patients with renal impairment. *Congestive heart failure* - While fenoldopam can increase renal blood flow, it is not a primary treatment for **congestive heart failure (CHF)** and is not typically used for its management. - Other drug classes, such as **diuretics**, **ACE inhibitors**, and **beta-blockers**, are the mainstays of CHF treatment. *Migraine prophylaxis* - Fenoldopam has **no role** in the prevention or acute treatment of migraines. - **Beta-blockers**, **calcium channel blockers**, and certain **antidepressants** are commonly used for migraine prophylaxis. *Tachyarrhythmias* - Fenoldopam **does not have antiarrhythmic properties** and is not indicated for the treatment of tachyarrhythmias. - **Beta-blockers**, **calcium channel blockers**, and specific **antiarrhythmic drugs** are used to manage tachyarrhythmias.

Q: Which ACE inhibitor is safe in renal failure?

Benazepril. ***Benazepril*** - Among the listed ACE inhibitors, benazepril has the **most favorable excretion profile** in renal failure with approximately **50% renal and 50% hepatic elimination** (dual excretion pathway). - This balanced elimination reduces the risk of drug accumulation compared to predominantly renally excreted ACE inhibitors. - While dose adjustment may still be needed in **severe renal impairment**, benazepril is considered the **safest option among those listed** for patients with renal dysfunction. - **Note:** Fosinopril (not listed here) has true 50/50 dual elimination and requires no dose adjustment in renal failure, making it the ideal choice in clinical practice. *Captopril* - This ACE inhibitor undergoes predominantly **renal excretion (95%)** as unchanged drug and metabolites. - Requires significant **dose reduction** in renal failure to prevent accumulation and adverse effects including **hyperkalemia** and **hypotension**. - Less safe than benazepril in renal impairment due to heavy dependence on renal elimination. *Enalapril* - Enalapril is a prodrug converted to **enalaprilat**, with approximately **90% renal excretion**. - Dose adjustment is mandatory based on **creatinine clearance** in patients with renal failure. - Higher risk of accumulation and toxicity compared to dual-elimination ACE inhibitors like benazepril.

Q: Which of the following is non-selective 3rd generation Beta blocker ?

Carvedilol. ***Carvedilol*** - **Carvedilol** is a **non-selective beta-adrenergic antagonist** (blocks both β1 and β2 receptors) with **additional α1-adrenergic blocking activity**, making it a true **3rd generation beta-blocker**. - The α1-blockade provides **vasodilatory properties**, reducing peripheral vascular resistance and improving hemodynamics. - It has favorable effects on lipid metabolism and insulin sensitivity, making it particularly useful in heart failure and hypertension. - Its non-selective beta-blockade combined with vasodilation distinguishes it from selective 3rd generation agents. *Betaxolol* - **Betaxolol** is a **selective β1-adrenergic antagonist** without vasodilatory properties. - Classified as a **2nd generation beta-blocker** due to its cardioselectivity. - Primarily used in glaucoma and hypertension but lacks the non-selective profile and additional mechanisms of 3rd generation agents. *Celiprolol* - **Celiprolol** is a **β1-selective antagonist** with **β2-agonistic effects** providing vasodilation. - While classified as 3rd generation due to vasodilatory properties, it is **selective for β1**, not non-selective. - Its β2-agonism causes peripheral vasodilation but maintains β1-selectivity. *Nebivolol* - **Nebivolol** is a highly **selective β1-adrenergic antagonist** with **vasodilatory effects via nitric oxide (NO) release**. - Classified as 3rd generation due to NO-mediated vasodilation, but it is **β1-selective**, not non-selective. - The combination of high β1-selectivity and endothelial-mediated vasodilation makes it unique among 3rd generation agents.

Q: Which of the following is not a known side effect of amiodarone?

Hyperglycemia. ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Q: Which class of antihypertensive drugs is known to cause erectile dysfunction?

Beta-blockers. ***Beta-blockers*** - **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction** - Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation - **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol) - Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction *Calcium channel blockers* - Generally have **neutral or minimal effect** on erectile function - May even improve ED in some patients due to **vasodilatory properties** - Side effects include peripheral edema and headache, but not sexual dysfunction *ACE inhibitors* - Associated with **lower risk of erectile dysfunction** compared to other antihypertensives - May have neutral or even protective effects on sexual function - Preferred choice for hypertensive patients with existing sexual dysfunction concerns - Common side effects: dry cough and angioedema (not related to sexual function) *AT1 receptor antagonists* - **ARBs have neutral to potentially beneficial effects** on sexual function - Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications - Some studies suggest they may improve erectile function in hypertensive patients

Question 1

Niacin therapy is contraindicated in diabetes because it

Accepted Answer

Increases the blood sugar levels

Answer

Causes scleroderma

Answer

Difficult to give injection

Answer

Increases the metabolism of oral hypoglycemic drugs

Question 2

Which drug is most classically associated with QT interval prolongation?

Accepted Answer

Quinidine

Answer

Magnesium Sulfate

Answer

Lignocaine

Answer

Amiodarone

Question 3

Drugs acting on K+ channels include which of the following?

Accepted Answer

Nicorandil

Answer

Methyldopa

Answer

Amiloride

Answer

Spironolactone

Question 4

Which of the following methods can reduce flushing caused by niacin?

Accepted Answer

All of the options

Answer

Tachyphylaxis

Answer

Laropiprant

Answer

Premedication with aspirin

Question 5

Which of the following medications is primarily used to decrease serum triglycerides?

Accepted Answer

Fibrates

Answer

Ezetimibe

Answer

Niacin

Answer

Statin

Question 6

Fenoldopam is used in the management of?

Accepted Answer

Hypertensive emergencies

Answer

Congestive heart failure

Answer

Migraine prophylaxis

Answer

Tachyarrhythmias

Question 7

Which ACE inhibitor is safe in renal failure?

Accepted Answer

Benazepril

Answer

Captopril

Answer

Enalapril

Answer

None of the options

Question 8

Which of the following is non-selective 3rd generation Beta blocker ?

Accepted Answer

Carvedilol

Answer

Betaxolol

Answer

Celiprolol

Answer

Nebivolol

Question 9

Which of the following is not a known side effect of amiodarone?

Accepted Answer

Hyperglycemia

Answer

Peripheral neuropathy

Answer

Hyperthyroidism

Answer

Skin discoloration

Question 10

Which class of antihypertensive drugs is known to cause erectile dysfunction?

Accepted Answer

Beta-blockers

Answer

Calcium channel blocker

Answer

ACE inhibitors

Answer

AT1 receptor antagonists

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?